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Abstract
The thioredoxin-dependent system is an essential regulator of cellular redox balance. Since oxidative stress has been linked
with neurodegenerative disease, we studied the roles of thioredoxin reductases in brain using mice with nervous system
(NS)-specific deletion of cytosolic (Txnrd1) and mitochondrial (Txnrd2) thioredoxin reductase. While NS-specific Txnrd2 null
mice develop normally, mice lacking Txnrd1 in the NS were significantly smaller and displayed ataxia and tremor. A striking
patterned cerebellar hypoplasia was observed. Proliferation of the external granular layer (EGL) was strongly reduced and
fissure formation and laminar organisation of the cerebellar cortex was impaired in the rostral portion of the cerebellum.
Purkinje cells were ectopically located and their dendrites stunted. The Bergmann glial network was disorganized and
showed a pronounced reduction in fiber strength. Cerebellar hypoplasia did not result from increased apoptosis, but from
decreased proliferation of granule cell precursors within the EGL. Of note, neuron-specific inactivation of Txnrd1 did not
result in cerebellar hypoplasia, suggesting a vital role for Txnrd1 in Bergmann glia or neuronal precursor cells.
Citation: Soerensen J, Jakupoglu C, Beck H, Fo¨rster H, Schmidt J, et al. (2008) The Role of Thioredoxin Reductases in Brain Development. PLoS ONE 3(3): e1813.
doi:10.1371/journal.pone.0001813
Editor: Dolph L Hatfield, National Institutes of Health/National Cancer Institute, United States of America
Received November 26, 2007; Accepted February 6, 2008; Published March 19, 2008
Copyright:  2008 Soerensen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Deutsche Forschungsgemeinschaft Priority Programme 1087 ‘‘Selenoproteins’’ to MC, MB and US. The supporting
foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Brielmeier@helmholtz-muenchen.de
. These authors contributed equally to this work.
Introduction
The thioredoxin (Txn) dependent system is one of the key systems
controlling cellular redox balance, and thus cell fate. Impaired
cellular redox balance has been linked with age-related diseases, and
neurodegenerative diseases, such as Alzheimer and Parkinson’s
disease [1]. Beyond its protective role, the Txn system is involved in
various cellular processes, such as cell-cell communication, tran-
scriptional regulation, cell signalling, and DNA synthesis [2].
The importance of the Txn system during embryo development
and adult physiology has been corroborated by loss-of function
approaches of individual members of this system in the mouse.
Targeted inactivation of cytosolic thioredoxin (Txn1) was associ-
ated with severe defects of inner cell mass proliferation and
embryonic death at the blastocysts stage [3]. Mice deficient for
mitochondrial thioredoxin (Txn2) displayed marked apoptosis,
anterior neural tube defects and embryonic lethality at E10.5 [4].
By contrast, overexpression of members of the thioredoxin family
promoted neuronal survival after various stresses. For instance,
Txn1 overexpression in mice had a neuroprotective effect on
neuronal cells when challenged with either focal brain ischemia [5]
or with the excitotoxin kainate [6]. Systemic administration of
recombinant human Txn1 decreased the extent of damage
induced by focal brain ischemia [7].
Txn activities are governed by the selenoenzyme family of
thioredoxin reductases [8]. There are three distinct genes in
mammals encoding cytosolic thioredoxin reductase (Txnrd1)[9],
mitochondrial thioredoxin reductase (Txnrd2)[10], and thiore-
doxin-glutaredoxin reductase (TGR or Txnrd3)[11]. While Txnrd1
and Txnrd2 are ubiquitously expressed in cells and tissues,
expression of Txrnd3 is mainly confined to testis. Thioredoxin
reductases are flavoproteins, form homodimers in a head to tail
alignment and possess two catalytically interacting reactive
centres. The C-terminally located redox active site contains an
essential selenocysteine residue; hence thioredoxin reductase
activity relies on the availability of dietary selenium (Se). While
some organs apparently exhibit a decreased demand for selenium,
it is strongly retained in the brain during experimental selenium
deficiency, arguing for essential roles exerted by one or several
selenoproteins in this organ [12]. Accordingly, impaired expres-
sion of selenoproteins in transgenic mice caused developmental
and degenerative damage in the brain [13–15].
Starting to dissect their contribution in embryonic development,
adult physiology and pathophysiology, we created mice with
conditional alleles of both Txnrd1 and Txnrd2 [16,17]. Ubiquitous
inactivation revealed that both genes are indispensable for
embryogenesis albeit in different ways. Txnrd1 knockouts exhibited
remarkable developmental, growth and neural tube closure
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retardation and embryonic death between E8.5 and E10.5.
Txnrd2-deficient embryos died shortly thereafter (E13.5) due to
severe anemia and growth retardation, resulting from perturbed
cardiac development and augmented apoptosis of hematopoietic
cells.
Expression profiling of Txnrd1 in embryos revealed highest
expression levels in neuronal tissues such as the developing forebrain,
rhombomeres and neural tube [17]. To ask whether thioredoxin
reductases are essential in brain development and function, we
inactivated both Txnrd1 and Txnrd2 individually in the nervous
system (NS) by using the Nestin-Cre transgenic mouse [18], which
expresses Cre in neuronal and glial precursor cells. NS-specific
Txnrd1 knockout mice were born at the expected frequencies, but
displayed growth retardation and striking a movement disorder,
suggestive of cerebellar dysfunction. By contrast, NS-specific
ablation of Txnrd2 or neuron-specific deletion of Txnrd1 did not
cause any obvious pathophysiological abnormalities.
Results
NS-specific Txnrd1 knockout mice are smaller and display
severe movement disorders
To decipher the individual contribution of cytosolic and
mitochondrial thioredoxin reductase in brain development and
maintenance, Txnrd1 and Txnrd2 expression in the central nervous
system (CNS) was disrupted in a tissue-specific manner. To bypass
embryonic lethality of Txnrd1 and Txnrd2 null embryos [16,17], we
used the Nestin-Cre (NesCre) transgenic mouse line, which targets
precursor cells of the neuronal and glial lineage, thus achieving
efficient gene deletion in both cell types [18,19]. Txnrd1-NS null
mice were born at the expected Mendelian ratio. Out of 197
offspring from NesCre;Txnrd1+/fl and Txnrd1fl/fl matings, 24% were
Txnrd1+/fl , 24% were Txnrd1fl/fl , 22% were NesCre;Txnrd1+/fl and
28% were NesCre;Txnrd1fl/fl.(Txnrd1-NS null). Likewise, mice
lacking Txnrd2 specifically in the NS were born at the Mendelian
ratio (data not shown).
The efficiency of Cre-mediated gene deletion of Txnrd1 and
Txnrd2 was monitored by immunoblotting, enzyme activity and
qRT-PCR as shown in figure 1 and figure S1 A, respectively.
While Txnrd1 protein levels in brain were only slightly reduced in
NesCre;Txnrd1+/fl mice compared to Txnrd1fl/fl control mice, the 55-
kDa immunoreactive band, representing Txnrd1 protein, was
virtually absent in the brains of Txnrd1-NS null mice (Fig. 1 A). In
accordance with the immunoblotting analysis, determination of
cytosolic Txnrd activity in brain and liver tissue revealed
significantly decreased cytosolic Txnrd activity in the brain of
Txnrd1-NS null mice compared to control littermates (Fig. 1 B).
qRT-PCR analysis of total RNA revealed very low levels of Txnrd2
transcripts in brain of Txnrd2-NS null mice (Fig. S1 A).
At birth, Txnrd1-NS null pups and Txnrd2-NS null pups were
indistinguishable from their littermates, but within the first days of
life, a deficiency in growth became apparent in Txnrd1-NS null
mice, whereas Txnrd2-NS null mice developed normally and did
not show any overt phenotype. NS-specific Txnrd1 knockout mice
slowly gained weight, reaching only about half the body mass
compared to their littermates at the age of 4 weeks (Fig. 2 A and
B). Already at P7, Txnrd1-NS null mice showed ataxic gait,
impaired balance, and tremor. After weaning, NS-specific Txnrd1
null mice were incapable of reaching food pellets in the wire bar of
the cage. Only when supplied with food pellets on the bottom of
the cage for the first couple of weeks, the knockout mice were able
to grow to adulthood. Male and female knockout mice were fertile,
and females could also foster their offspring normally (data not
shown). In order to quantify the movement defect, Txnrd1-NS null
and control mice were subjected to a modified pole test [20], an
assay for coordinated movement (Fig. 2 C). While control animals
were able to climb down the pole in approximately 30 seconds,
Txnrd1-NS null mice mostly failed in doing so. 11 out of 14 tested
mutants slid or dropped down.
Cerebellar hypoplasia, abnormal foliation and perturbed
lamination in the cerebellum of NS-specific Txnrd1
knockout mice
While most brain regions, including the olfactory bulb,
subventricular zone and the cerebral cortex, did not reveal any
histological abnormalities in Txnrd1-NS null mice, the cerebellar
cortex displayed striking morphological alterations. In contrast, no
morphological abnormalities could be detected in Txnrd2-NS null
mice, indicating that Txnrd1, rather than Txnrd2, plays a vital
role for brain development. Further histological analyses were
performed in Txnrd1-NS null mice to define the developmental
abnormalities in the cerebellum. For a thorough spatiotemporal
analysis of the cerebellar phenotype, serial sagittal sections of
brains from control and Txnrd1-NS null mice at different
embryonic stages (E11.5, E15.5 and E18.5) and various postnatal
stages were prepared (Fig. 3). Cerebellar dimensions were
determined morphometrically (Fig. 4). At developmental stages
E11.5 (data not shown) and E15.5, no differences between
knockout and control animals were evident. Overall cerebellar
size and external granular layer (EGL) thickness were indistin-
guishable among mice of the different genotypes. From as early as
E18.5 until the end of cerebellar development at postnatal stage
P21, cerebellar morphology of the mutants substantially differed
Figure 1. Txnrd1 expression is strongly reduced in Txnrd1-NS
null mouse brain. (A) Western blot analysis of cytoplasmic brain
protein extracts, revealing strongly reduced Txnrd1 protein levels in
brain tissue of Txnrd1-NS null mice as compared to control mice. 30 mg
protein were separated per lane. a-tubulin served as loading control. (B)
Thioredoxin reductase activities were significantly reduced in the
cytosol of Txnrd1-NS null brain but not of control brain nor of liver
tissue regardless of genotype.
doi:10.1371/journal.pone.0001813.g001
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from that of control animals, particularly in its size, cerebellar
cortical folding and lamination. Cerebellar size differences became
evident from P7 onwards (Fig. 3 and Fig. 4 C). At weaning, the
area of the knockout cerebellum was only one fourth of that of the
controls. Massive proliferation within the EGL, producing granule
neurons, is mainly responsible for the postnatal expansion of the
cerebellum [21]. In normal development, it comprises 7–10 cell
layers at P7, decreasing thereafter, and eventually disappears by
P21 [22]. However, from P1, the EGL in the anterior cerebellum
of the mutants was thinner than in control animals (Fig. 3),
resulting in strongly diminished expansion of the tissue in this area.
In order to delineate the mechanism, underlying cerebellar
hypoplasia in Txnrd1-NS null mice, proliferation of granule cell
precursors was quantified by immunostaining for mitotic cells
using the mitosis marker phosphorylated histone H3 (PH3) [23]
(Fig. 4 A and B). In control mice, EGL proliferation was highest at
postnatal day 7, whereas in Txnrd1-NS null mice the number of
proliferating cells was approximately three times lower at P7, and
around two times lower at P14 compared to control mice. The
Figure 2. NS-specific Txnrd1 knockout mice display restricted
growth and striking movement disorders. (A) Shown are a Txnrd1-
NS null mouse (right) and a control littermate (left) at the age of
1.5 years. (B) Determination of body weight at various time points
revealed impaired growth of Txnrd1-NS null mice compared to control
littermates. Values are expressed as mean6SD. (C) Motor coordination
performance was tested using the pole test. Shown is the time required
to climb down the vertical pole on 5 consecutive trials. If a mouse fell
down, slipped or was unable to climb down, a default value of 120 s
was taken into account. (P = postnatal day).
doi:10.1371/journal.pone.0001813.g002
Figure 3. Striking cerebellar hypoplasia in Txnrd1-NS null mice.
H&E staining of midline sagittal cerebellar sections from control (left
column) and Txnrd1-NS null mice (right column) at embryonic stages
E15.5, E18.5 and at postnatal days P1, P7 and P21 showed progressive
differences in the foliation and formation of the molecular-, Purkinje
cell- and granular layers during development of the cerebellum. In each
photograph, the anterior part of the cerebellum is located to the left
and the dorsal part to the top. At E15.5, no difference in cerebellar
development is visible. At E18.5, the cerebellum is smaller and the
formation of the primary fissure is slightly retarded in Txnrd1 null brains.
The external granular layer (EGL), which is the source of cells for the
granular layer, is hypoplastic particularly in the anterior cerebellar area
in Txnrd1-NS null mice at P1. Higher magnification demonstrated clear
differences in the EGL thickness at P1 and P7 as well as the ectopic
localisation of Purkinje cells and the absence of a well-organized,
trilaminar-stuctured cerebellum. Already from E18.5 onwards, the
Txnrd1 null cerebella are smaller when compared to controls, and the
laminar organisation of the mutant cerebellum becomes progressively
more distorted in the anterior part. At P21, the posterior lobules X to VII
of the knockout mice appear relatively well developed, whereas within
lobules VI–V there is an abrupt transition from an apparently normally
structured cortex to a disrupted cortex. Finally, in the abnormally
structured anterior region (Lobules V–I) the IGL is missing and the PCs
are ectopic. In addition, the IGL is missing and the PC are ectopically
localised (abbreviations: EGL= External granular layer, PC = Purkinje
cells, IGL = internal granular layer, Pf = primary fissure). Lobules are
indicated by roman numerals I–X. Scale bar: E15,5: 100 mm; E18,5, P1:
200 mm; P7, P21: 0,5 mm.
doi:10.1371/journal.pone.0001813.g003
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strongly impaired proliferation eventually resulted in a strongly
reduced cell density of the granular layer particularly in the
anterior part of the knockout cerebellum (Fig. 4 D). This effect was
limited to granular cells, as the number of Purkinje Cells was
unaffected (Fig. 4 D). To examine whether increased programmed
cell death may contribute to the dramatically reduced size of the
cerebellum during development, sagittal sections of P7 cerebella
from Txnrd1-NS null mice and controls were stained for apoptotic
cells [24]. However, no difference in the ratio of TUNEL-positive
cells was apparent between control and mutant mice, indicating
that increased cell death does not substantially contribute to
impaired cerebellar size (Fig. S2).
Figure 4. Reduced proliferation in Txnrd1 null cerebellum. (A) To visualize mitotic cells, immunohistochemial staining on paraffin-embedded
sagittal sections of P7 cerebelli were performed with an anti-phosphorylated histone 3 (PH3) antibody. Sections were counterstained with Mayer’s
haemalaun. Scale bar: 200 mm. (B) Illustrated is the number of PH3-positive cells per visual field from E11.5 until completion of postnatal cerebellar
development at P21. (C) Txnrd1-NS null mice show a reduced cerebellar size from P1 onwards. Dashed line indicates the measured area. (D) Adult null
mice show a strongly reduced relative cell density of the granular layer in the anterior cerebellum and only a slight reduction in the posterior part.
The number of Purkinje cells remained unaffected.
doi:10.1371/journal.pone.0001813.g004
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Owing to the massive proliferation of granule cell precursor
cells, the cerebellar cortex expands, finally developing into a folded
structure with 10 main vermal lobules (designated I to X).
Cerebellar development is completed by P21. In Txnrd1-deficient
brain, the absence of major proliferation in the anterior region of
the cerebellum leaves this folding unnecessary, and thus only
lobules VII to X are formed (Fig. 3).
Besides the differences in size and foliation, there was a striking
lamination defect in the anterior part of the Txnrd1-deficient
cerebellum. The definitive cerebellar cortex consists of a molecular
layer, a Purkinje cell (PC) layer and an internal granular layer.
PCs, originating from the ventricular zone, migrate along the
Bergmann glial fibers to settle in a dense zone beneath the forming
EGL. Terminal differentiation of PCs occurs postnatally when
they become arranged in a monolayer and make contact with the
parallel fibers of the granule cells [25]. The granular neurons
forming the internal granular layer descend from the EGL after
exiting the cell cycle and move radially from the outer cerebellar
surface beneath the PC layer along the guiding Bergmann glia,
thereby making their connections with the PC dendrites. These
developmental events were severely disturbed in the cerebellum of
the mutants and the anterior part became progressively more
distorted throughout postnatal development (Fig. 3). The anterior
cerebellum showed an ectopic PC localisation (Fig. 3, P7), no
formation of distinctive molecular-, PC- and granular layer and
fusion of the lobules. In the posterior part, however, lamination
did not grossly deviate from the normal cerebellar development.
To determine the roles of different cell types in the lamination
phenotype, we performed immunohistochemical stainings (Fig. 5)
[26–28]. By P1, staining for Nestin (Fig. 5) and GFAP (data not
shown) revealed a clew-like alignment and shortening of Bergman
glia in the anterior cerebellum of the mutant. By P14, a significant
change in the distribution the GFAP-protein in the anterior
mutant cerebellum, loss of radial alignment and reduction of
thickness were detectable (Fig. 5). This was not observed in the
posterior area of Txnrd1-NS null mice.
Immunostaining with the PC marker Calbindin (Fig. 5) clearly
supports the ectopic localisation of PCs in the fused anterior
cerebellar area, confirming the data already obtained by HE
staining (Fig. 3, P7). In addition, architecture of the dendritic trees
in the mutants was less elaborated (Fig. 5, inlays). PC dendritic
trees along with the parallel fibers of granular neurons as well as
basket- and stellate cells predominantly form the molecular layer,
which does not separate in the anterior part of the mutants (Fig. 3
and Fig. 5). Immunostaining for parvalbumin, another marker for
Purkinje cells, corroborated these findings (data not shown).
Postmitotic neurons of the granular layer were detected by NeuN
expression (data not shown) [29]. This staining supported the
disrupted formation of the granular layer in the mature anterior
cerebellum of Txnrd1-NS null mice as also revealed by the H&E
staining (Fig. 3). In summary, the development of cerebellar
lobules was defective in Txnrd1-NS null mice, showing fusion of
lobule I–VI. In this anterior part, the principal laminae, molecular
layer, PC layer, and granule layer, did not form. The lobules in the
posterior cerebellar area (lobules VI–X) of Txnrd1-NS null mice
were smaller but the laminar organisation was normal.
In order to further dissect the roles of neurons and glial cells in
Txnrd1-dependent developmental processes, we additionally gener-
ated neuron-specific Txnrd1 knockout mice (Ta1-Cre;Txnrd1fl/fl)
[30,31]. Interestingly, cerebellar foliation was completely normal
in these mice (Fig. 6 A, B). Accordingly, there were no behavioural
abnormalities or growth defects in these mice (not shown). Cytosolic
thioredoxin reductase activity measurements were performed to
demonstrate targeted inactivation of Txnrd1 in neuronal cells (Fig. 6
C). Thioredoxin reductase activity was reduced by half, consistent
with remaining Txnrd1 expression in glial cells. Thus, since Nestin-
Cre causes excision of loxP flanked genes in neuronal and glial
precursor cells, butTa1-Cremice are specific for postnatal neurons, it
is tempting to assume that the cerebellar phenotype in Txnrd1-NS
null mice is caused by disruption of Bergmann glia function and/or
diminished proliferative capacity of granule cell precursors.
Discussion
The thioredoxin (Txn) dependent system, comprising of
cytosolic (Txn1) and mitochondrial (Txn2) thioredoxins, various
Txn dependent peroxidases (peroxiredoxins) and the selenoen-
zymes thioredoxin reductases 1–3, is one of the major redox
systems in cells involved in the control of cellular redox balance
[2,8]. While the Txn dependent system has been suspected to play
a significant role in brain tissue, only very little information on its
physiological role in brain development and function has been
available to date.
To address the individual roles of members of the thioredoxin
reductase family in brain development and function, we
conditionally disrupted Txnrd1 and Txnrd2 expression in brain
using neural-specific and neuron-specific Cre transgenic mice.
Thus, expression of Txnrd1 and Txnrd2 is abrogated as early as in
neuronal progenitor cells [18] or early postnatal neurons [30].
Cre-mediated inactivation was highly efficient in Txnrd1- and
Txnrd2-NS null mice. While expression levels of Txnrd1 were very
low in the brain of Txnrd1-NS null mice, residual cytosolic
thioredoxin reductase activity could be detected in these mice,
which may be attributed to cytosolic Txnrd2. Several recent
reports indicated that Txnrd2 is also expressed in the cytosolic
compartment [11,32], though its subcellular localisation in tissues
and organs remains to be elucidated. Surprisingly, mice specifi-
cally lacking Txnrd2 in the NS develop normally, do not show any
histopathological deterioration and have a similar life span as
control littermates (data not shown). By contrast, NS-specific
Txnrd1 knockout mice exhibit reduced weight gain from P7
onwards and developed severe ataxia, suggestive of major
cerebellar defects. Nonetheless, NS-specific Txnrd1 knockout mice
survived and could even generate and foster viable offspring. Our
data imply that it is Txnrd1 and not Txnrd2 that plays a critical
role in brain development, however this does not rule out any
contribution of Txnrd2, for instance under pathological conditions
such as stroke and trauma. Interestingly, in our two previous
studies we could clearly assign a crucial role for Txnrd2 in heart
development and function [16], while Txnrd1 function turned out
to be negligible for cardiac development and function [17]. Thus,
both enzymes do not emerge as mere housekeeping genes, but
fulfil tissue and organ-specific functions.
We observed a clear compartment boundary between the
widely normally developed posterior cerebellum (lobules VII–X)
and the strongly disorganized anterior part (lobules I–VI) in
Txnrd1-NS null mice. This phenomenon has been previously
found in a number of other cerebellar aberrations [33–35], and
has been interpreted as a general developmental principle in
cerebellar development [34]. Most interestingly, loss-of genetic loci
causes a phenotype either in the anterior or the posterior part of
the cerebellum. Meander tail (Mea) for example has an
appearance that very closely resembles the Txnrd1-NS null
phenotype, whereas BETA2/NeuroD1-knockout has a posterior
defect [36]. In contrast to our findings, the cell types primarily
affected by the Mea mutation are the granular neurons. The
molecular and cellular mechanisms leading to the Mea phenotype,
however, have not been described yet.
Txnrds in Brain Development
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Histopathological analysis of Txnrd1 null brain revealed striking
cerebellar hypoplasia, in particular of lobules I–VI. Proper
foliation requires a complex, well-coordinated series of develop-
mental steps, including proliferation or death of granule cells [37],
migration along Bergmann glial fibers [38] and outgrowth of PC
dendrites [22]. All these processes are intricately connected [39],
e.g. granule cell precursor proliferation depends on sonic
hedgehog released by PC [40], and induction of a radial glial
phenotype of Bergmann glia requires the release of Neuregulin by
granule cells. Since increased cell death is not observed, but
reduced numbers of mitotic granule cell precursors, the major
defect underlying cerebellar hypoplasia might result from
diminished proliferation of granule cells, the driving force of
cerebellar growth and foliation. In fact, it has been demonstrated
recently that increasing sonic hedgehog signalling in the mouse
cerebellum (by modulating patched expression) can induce the
formation of an additional lobe at the same position where it exists
in rats [40]. A major role for Txnrd1 in postnatal proliferation of
granule cells is also suggested by the normal embryonic
development of the cerebellum. The use of two different Cre-
transgenic mice to disrupt Txnrd1 allowed us to rule out a major
role of neuronal Txnrd1 for cerebellar morphogenesis. Thus,
Figure 5. Glial disorientation, lobular fusion and ectopic localisation with reduced arborisation of Purkinje cells in anterior
cerebellum of Txnrd1-NS null mice. Immunohistochemical staining of paraffin-embedded sagittal cerebellar slides using anti-Nestin (P1), anti-
GFAP, and anti-Calbindin (both P14) counterstained with Mayer’s haemalaun. The anterior and posterior cerebellar areas, represented in the high
power micrographs shown in the lower part of the figure, are indicated by a filled box or an open box, respectively. Bergman Glia, shown as anti-
Nestin or anti-GFAP immunoreactive cells, is essential for neuronal migration during pre- and postnatal cerebellar development. Clew-like alignment
and shortening of Bergman glia is found in the anterior cerebellum of the mutant in 1 day old mutants (upper centre) or 14 day old mutants (middle
centre). Anti-GFAP immunoreactive Bergmann glial fibers are shorter, disoriented, and reduced in density in the affected anterior Txnrd1-NS null
lobules compared to control animals which show a radial alignment of these cells towards the pial surface (middle left). Glial cells in the posterior area
of the Txnrd1-NS null cerebellum appear normal (upper and middle right). Purkinje cells, which are immunoreactive with anti-Calbindin, are located in
a monolayer and project their dendrites towards the cells of the molecular layer in control mice (lower left). In the dysmorphic anterior Txnrd1-NS null
cerebellum, ectopic Purkinje cell bodies in numerous layers fill the merged lobules and show impaired dendritic arborisation (lower centre). Purkinje
cells of the mutant posterior cerebellar area show the same features, although less pronounced (lower right). Scale bar: 25 mm, anti-Calbindin
staining: 200 mm.
doi:10.1371/journal.pone.0001813.g005
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either radial glial (Bergmann) cells and/or granule cell precursors
are the cell type likely affected by Txnrd1-deficiency.
Interestingly, neither the cerebellar anlage nor any other part of
the brain seems to be affected by loss-of Txnrd1 using NesCre. This
is a remarkable finding, since virtually all neurons show Nestin
expression during their development. This finding is underscored
by the complete absence of Txnrd1 protein observed in brain
homogenates from Txnrd1-NS null mice. So why is the cerebellum
apparently more affected than other brain regions that also
descend from proliferation of neuroepithelial cells? If we assume
the granule cell precursors as the primarily affected cell type, they
are distinguished from most other proliferative epithelia in being a
secondary neuroepithelium. There is, however, no indication why
a secondary neuroepithelium should specifically rely on Txnrd1.
Another difference is the massive proliferation, occurring during
postnatal cerebellar expansion. In fact, granule cells are the single
most abundant cell type in the brain. Thus, if Txnrd1 is absent,
insufficient provision of electrons for ribonucleotide reductase
[41,42] (the commited step in DNA synthesis) during massive
expansion might become the limiting step in tissue development.
Of interest, neuronal progenitor cell-specific ablation of N-myc
using the Nestin-Cre, resulted in a similar cerebellar phenotype as in
the like NS-specific Txnrd1 knockout mice [43]. NS-specific N-myc
null mice show ataxia and behavioural abnormalities, associated
with a strong reduction in cerebellar size. Drops in mitotic cells
and cells in S-phase along with reduced expression of the N-myc
target gene cyclin D2 were considered being responsible for
cerebellar hypoplasia in N-myc null brain. Txnrd1 has been
identified as direct c-Myc target gene in a human B cell line
[44]. Since members of the Myc transcription factor family are
largely interchangeable [45], and n-Myc constitutes the major
isoform of the Myc family in brain, one may propose that Txnrd1 is
one of the most significant target genes of n-Myc in brain. Also,
the Txn1/Txnrd1 system has been frequently linked with
Figure 6. Mice with neuron-specific disruption of Txnrd1 are phenotypically indistinguishable from wild-type litter mates. (A)
Histological analysis of cerebellum revealed normal size and foliation pattern of the cerebellum of Ta1-Cre;Txnrd1fl/fl mice (with neuron-specific
disruption of Txnrd1, right panel) in comparison to control mice (left panel) at the age of 5 weeks. Purkinje cells are stained with an antibody against
Calbindin. (B) Higher power magnifications from (A). Sections were counterstained with Nissl. (B) Reduced cytosolic thioredoxin reductase activity in
neuron-specific Txnrd1 knockout mice. Residual activity most likely resides in glial cells. Scale bars: 250 mm
doi:10.1371/journal.pone.0001813.g006
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proliferation of many tumors and tumor cell lines [46–48]. Thus,
our present finding along with our previous studies, in which we
observed a pronounced overall proliferation defect in Txnrd1 null
embryos except in the heart [17], corroborate the importance of
Txnrd1 for cell proliferation and tissue development. It is,
however, somewhat surprising that other regions of the brain
apparently do not require functional Txnrd1 or Txnrd2. It thus
remains open, whether thioredoxin reductase 3 (also called
thioredoxin-glutaredoxin reductase) may replace Txnrd1 or
Txnrd2 [11], or alternatively that Txnrd2 may functionally
compensate for dysfunctional Txnrd1 at least for normal
proliferation. This possibility might be answered by generating
compound mutant mice in which both isoforms are simultaneously
inactivated in the brain. Of note, knockout mouse models for
enzymes of the cell cycle progression machinery, including cyclin
D2 [49] or compound mutant mice lacking cyclins D1 and D2
[50] also develop similar phenotypes in the cerebellum, albeit to a
different degree. Hence, Txnrd1 might be viewed as an additional
major player of the cell proliferation machinery.
Recent data implied that truncated forms of Txnrd1, lacking the
C-terminally located catalytically important selenocysteine might
exert pro-apoptotic functions [51,52]. Since our targeting
strategies aimed at inactivating the C-terminal catalytic centers
of Txnrd1 and Txnrd2, we cannot rule out that minute amounts of
Txnrd1 or Txnrd2 are still made in knockout brains, possibly
causing unwanted side effects. But in our NS-specific knockout
models, we could never detect any changes in the number of
apoptotic cells, even in aged brain (data not shown).
Selenium depletion experiments in rodents demonstrated that
selenium is strongly retained in brain, suggesting vital functions for
one or several selenium dependent enzymes for neuronal and non-
neuronal cells. Accordingly, mice with targeted disruption of
selenoprotein P, a selenoprotein of the selenium delivery pathway
to organs, show seizures and ataxic gait [13]. Neuron-specific
ablation of selenoprotein expression, achieved by neuron-specific
removal of the tRNA for selenocysteine, leads, among other
phenotypes, to cerebellar hypoplasia. However, the defect is
histologically distinct from that observed in NS-specific Txnrd1
knockout mice (E. Wirth U.S., unpublished).
The Txn1-Txnrd1 system has been implicated in Alzheimer’s
disease. Altered expression levels have been observed in patients
suffering from Alzheimer’s disease, and pre-treatment of primary
hippocampal cultures with either Txn or Txnrd appear to
ameliorate the effects of amyloid b [53]. Likewise, oxidation of
glutaredoxin 1 and thioredoxin 1 in response to amyloid b treatment
has been shown to activate apoptosis signal-regulating kinase
(ASK1), suggesting that a deregulated antioxidant system including
thioredoxin 1 might be critical in the sequelae leading to Alzheimer
[54]. In future experiments, our models might prove most suitable to
investigate the role of the Txn1/Txnrd1 system in animal models of
Alzheimer’s Diseases or other neurodegenerative diseases.
Materials and Methods
Generation and maintenance of tissue-specific knockout
mice
To generate neuronal progenitor cell-specific or neuron specific
thioredoxin reductase-deficient mice, mice with conditional alleles
for either Txnrd1 (Txnrd1tm1Marc) [17] or Txnrd2 (Txnrd2tm1Marc)[16]
were crossed with Nestin-Cre transgenic mice [18] or Ta1-Cremice,
respectively [30]. Two consecutive breeding steps were required.
First, loxP-flanked (floxed; fl) Txnrd1tm1Marc (designated as Txnrd1+/fl)
and Txnrd2tm1Marc (designated as Txnrd2+/fl) knockout mice were
bred with Nestin-Cre or Ta1-Cre transgenic mice to obtain
NesCre;Txnrd1+/fl, Ta1-Cre;Txnrd1+/fl, and NesCre;Txnrd2+/fl mice,
respectively. Subsequently, these mice were mated with Txnrd1fl/fl
or Txnrd2fl/fl mice to obtain NesCre;Txnrd1fl/fl (designated as Txnrd1-
NS null mice in the text), Ta1-Cre;Txnrd1fl/fl (designated as neuron-
specific Txnrd1 knockout mice), and NesCre;Txnrd2fl/fl mice (desig-
nated as Txnrd2-NS null mice in the text), respectively. Heterozygous
knockout mice behaved like wild-type in all assays, and thus
NesCre;Txnrd1+/fl, Txnrd1fl/fl, Txnrd1+/fl and NesCre;Txnrd2+/fl,
Txnrd2+/fl, Txnrd2+/fl littermates served as controls. Mice were kept
under standard housing conditions with food (type 1314, Altromin
GmbH, Lage, Germany) and water ad libitum. All animal
experiments were performed in compliance with the German
animal welfare law and have been approved by the institutional
committee on animal experimentation and the district governments
of Upper Bavaria and Berlin. Genotyping of mice was performed by
PCR of tail DNA as described previously [16,17].
Immunoblotting
Preparation of total and cytosolic protein fractions from tissue was
carried out as described [17]. Protein concentrations were deter-
mined by the Bradford assay (Bio-Rad Labs GmbH, Munich,
Germany). 20 mg of cytosolic proteins were separated on a 10% SDS-
PAGE and blotted onto a nitrocellulose membrane (Hybond ECL,
Amersham Biosciences, RPN 303D). For detection, a rabbit anti-
Txnrd1 (1:2000 dilution, Lab Frontier, LF-PA0023, Seoul, Korea),
and a goat anti-rabbit horseradish peroxidase conjugated secondary
antibody (1:2000 dilution, Bio-Rad Labs GmbH, Munich, Germany)
were used. Signals were visualized by an enhanced chemolumines-
cence kit (Amersham Biosciences, RPN 2106).
RNA isolation, cDNA synthesis and quantitative RT-PCR
(qRT-PCR)
Isolation of total RNA, DNAse treatment of RNA and reverse
transcription was carried out as described [16]. qRT-PCR was
carried out using a Roche LightCycler H 2.0 Real-Time PCR System
according to the manufacturer’s recommendations (Roche Diag-
nostics, Mannheim, Germany). Txnrd2 levels were normalized
against 18S ribosomal RNA. Primers used for Txnrd2 quantification
were: E6/E10forw.: 59-CAGCTTTGTGGATGAGCACACAGT-
TCG-39, E6/E10rev.:59-GATCCTCCCAAGTGACCTGCAGC-
TGG-39, E15/E18forw.:59-TTCACGGTGGCGGATAGGGAT-
GCTC-39, E15/E18rev 59-TGCCCAGGCCATCATCATCT-
GACG-39, S18forw.:59-GGA CAG GAT TGA CAG ATT GAT
AG-39, S18rev.: 59-CTC GTT CGT TAT CGG AAT TAA C-39.
Determination of thioredoxin reductase activity
Thioredoxin reductase activity was determined by the NADPH-
dependent DTNB reduction assay (Holmgren and Bjornstedt, 1995).
100 mg of the cytosolic fraction was added to the reaction mixture,
containing 0.1 M potassium phosphate, pH 7.0, 1 mM EDTA,
2 mg/ml DTNB (Sigma-Aldrich GmbH, Seelze, Germany),
0.2 mg/ml NADPH (10107824001, Roche Diagnostics,Mannheim,
Germany), and 0.2 mg/ml bovine serum albumin. Absorption at
412 nm was measured in a spectrophotometer (SmartSpec TM Plus,
BioRad GmbH, Munich, Germany). Txnrd1 activity is expressed as
nmol oxidized NADPH/(min * mg of protein).
Pole test
The pole test was performed according to Fernagut et al. [20],
with minor modifications. 14 Txnrd1-NS null and 14 control
littermates were placed head downwards on top of a vertical
rough-surfaced pole (diameter 1 cm, 50 cm height). Nesting
material was placed at the bottom of the pole to avoid injury.
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Each mouse was habituated to the pole on the day prior to testing
(five trials). The total time until the mouse reached the floor with
its four paws was recorded (T-total). Animals received five trials
with an inter-trial interval of 30 s. If the mouse was unable to
climb down, fell or slipped, a default value of 120 s was taken into
account.
Histological analysis
Embryos dissected at various developmental stages (E11.5,
E15.5, E18.5) as well as brains from animals at postnatal stages P1,
P7, P14, P21 and two years old were analyzed. Freshly dissected
embryos and tissue samples were fixed overnight in 4% (w/v)
paraformaldehyde (4% PFA) in phosphate buffered saline (PBS) or
in Bouin’s fixative, stored in 70% ethanol, embedded in paraffin,
and cut in sections of 7 mm (embryos) and 8 mm (brains). For
hematoxylin-eosin (HE) staining, sections were deparaffinized in
xylol, rehydrated in graded ethanol series, stained with Mayer’s
haemalaun (Carl Roth, Karlsruhe, Germany) for 5 min, washed
again, and stained with 1% eosin (Carl Roth, Karlsruhe, Germany
for 2 minutes). The sections were washed in water, dehydrated in
graded ethanol series, treated with xylol, and mounted. Nissl
staining was carried out as described [55].
Immunohistochemical stainings
Immunohistochemistry on paraffin-embedded sections was
carried out as described previously [16,17]. Following primary
antibodies were used: anti-phosphorylated histone H3 (PH3)
(9701, Cell Signaling NEB GmbH, Frankfurt, Germany), anti-
GFAP (MAB360), anti-calbindin (AB1778), anti-Nestin
(MAB353), anti-Parvalbumin (MAB 1572) and anti-NeuN
(MAB377, all Chemicon GmbH, Schwalbach, Germany). Bioti-
nylated secondary antibodies were purchased from Vector labs,
Ohio, USA. To visualize bound secondary antibodies, staining was
performed according to the manufacturer’s protocol (Vectastatin
Elite ABC kit PK-6100 and DAB kit SK-4100, Vector Labs. Ohio,
USA). Sections were counterstained with Mayer’s haemalaun
(Carl Roth, Karlsruhe, Germany). To avoid non-specific binding
5% BSA/PBS-solution (MP Biomedicals) was used for blocking.
In situ end labelling
For monitoring apoptotic cells in Txnrd1-NS null and control
animals, PFA-fixed (4% (w/v) paraformaldehyde in PBS) and
paraffin-embedded sections were stained with the ApopTag kit
(S7100, Serologicals Corporation, Norcross, GA, USA) according
to the manufacturer’s instructions. Digoxigenin-deoxynucleoside
triphosphate-labelled cells were incubated with an anti-digox-
igenin peroxidase conjugate and visualized with 3,39-diaminoben-
zidine (DAB, Vector Labs, Ohio, USA). Sections of testis from
C57Bl/6 animals served as positive control.
Morphometrical and quantitative analyses
Documentation of the sections was performed using an
Axioplan 2 microscope and Axiovision 3.1 software (Zeiss,
Oberkochen, Germany). Mitotic cells (PH3-positive cells): The
number of PH3-positive cells in the cerebellum per section were
counted on sections from two Txnrd1-NS null and two control
animals at developmental and neonatal stages E11.5, E15.5,
E18.5, P1, P7, P14, and P21. Cerebellar area: Measurement of the
cerebellar area in midsaggital sections of two Txnrd1-NS null and
control animals was performed by using the Axiovision LE 4.1
software (Zeiss, Oberkochen, Germany) at stages E15.5, E18.5,
P1, P7, P14, and P21. Relative cell counts in the cerebellar
granular layer and number of Purkinje cells1: Quantification of
cells in the anterior and posterior part of the cerebellum (three
knockouts and three controls, adult animals) was calculated as
described previously (Leung et al., 2004), using the ImageJ
program (http://www.uhnresearch.ca/facilities/wcif/imagej/) for
granular cells. Purkinje cells were counted directly on the
microscope.
Supporting Information
Figure S1 Txnrd2 is dispensable for brain development. (A)
Quantitative RT-PCR analysis of total brain RNA revealed that
Txnrd2 transcripts were strongly reduced in Txnrd2-NS null mice
(empty bars) compared to control mice (filled bars). Two primer
pairs, one specifically detecting the core region of Txnrd2 (E6/E10)
and one specific for the deleted region (E15/E18) were used.
Txnrd2 expression was normalized to 18S rRNA expression levels
(shown is the mean +/2 SD) (B) H&E staining of mid-sagittal
cerebellar sections from adult control (left column) and Txnrd2-NS
null mice (right column). The cerebellum, like other brain regions
(data not shown), did not display any defects in lamination and
foliation. Scale bars: 250 mm. (C) TUNEL staining of brain
sections did not show any increases in the number of apoptotic
cells in the cerebellum of Txnrd2-NS null brain. Germinal
epithelium of testicular tissue served as a positive control (inlay).
Scale bars: 50 mm. Cerebellar lobules are indicated by roman
numerals I–X.
Found at: doi:10.1371/journal.pone.0001813.s001 (2.53 MB TIF)
Figure S2 Apoptotic cell numbers are unaltered in the Txnrd1-
NS null cerebellum. (A) Apoptotic cells (arrowheads) are
commonly found in the germinal epithelium in testis, which
served as a positive control. (B) Negative control without primary
antibody: no imunoreactivity with the secondary antibody.
Illustrated are the anterior cerebellar regions from a control
mouse (C) and a Txnrd1-NS null mouse (D). Arrowheads show
apoptotic cells in the EGL. There is no increased level of apoptosis
in the cerebellum of the mutants. Abbreviations are as follows; SC:
Sertoli cell; SpG: Spermatogonium; PrS: Primary spermatocytes;
SpT: Spermatids. EGL: External granular layer; IGL: Internal
granular layer; PC: Purkinje cell layer. Arrowheads indicate
apoptotic cells. Scale bars: 50 mm.
Found at: doi:10.1371/journal.pone.0001813.s002 (2.00 MB TIF)
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